Cargando…
Nivolumab-induced tumour-like gastritis: A case report
BACKGROUND: Immune checkpoint inhibitors are one of the modern treatment methods for advanced malignancies. However, this group of medications is also associated with various immune-related adverse events, such as colitis or pneumonitis. Immune checkpoint inhibitor-induced gastritis is a less common...
Autores principales: | Cijauskaite, Elena, Kazenaite, Edita, Strainiene, Sandra, Sadauskaite, Goda, Kurlinkus, Benediktas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336988/ https://www.ncbi.nlm.nih.gov/pubmed/37449232 http://dx.doi.org/10.12998/wjcc.v11.i18.4350 |
Ejemplares similares
-
Crohn’s disease in human immunodeficiency virus-infected patient: A case report
por: Vinikaite, Ausra, et al.
Publicado: (2023) -
Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022) -
Severe steroid refractory gastritis induced by Nivolumab: A case report
por: Vindum, Helene Hjorth, et al.
Publicado: (2020) -
Severe Gastritis after Administration of Nivolumab and Ipilimumab
por: Nishimura, Yoshito, et al.
Publicado: (2018) -
Severe Esophagitis and Gastritis from Nivolumab Therapy
por: Boike, Justin, et al.
Publicado: (2017)